ONCY
Price
$0.97
Change
+$0.06 (+6.59%)
Updated
Dec 24, 02:00 PM (EDT)
72 days until earnings call
UBX
Price
$0.99
Change
-$0.01 (-1.00%)
Updated
Dec 24, 01:59 PM (EDT)
Ad is loading...

ONCY vs UBX

Header iconONCY vs UBX Comparison
Open Charts ONCY vs UBXBanner chart's image
Oncolytics Biotech
Price$0.97
Change+$0.06 (+6.59%)
Volume$607
CapitalizationN/A
Unity Biotechnology
Price$0.99
Change-$0.01 (-1.00%)
VolumeN/A
CapitalizationN/A
ONCY vs UBX Comparison Chart
Loading...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONCY vs. UBX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONCY is a Hold and UBX is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (ONCY: $0.97 vs. UBX: $1.00)
Brand notoriety: ONCY and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONCY: 326% vs. UBX: 42%
Market capitalization -- ONCY: $75.59M vs. UBX: $16.85M
ONCY [@Biotechnology] is valued at $75.59M. UBX’s [@Biotechnology] market capitalization is $16.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONCY’s FA Score shows that 0 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • ONCY’s FA Score: 0 green, 5 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, UBX is a better buy in the long-term than ONCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONCY’s TA Score shows that 4 TA indicator(s) are bullish while UBX’s TA Score has 4 bullish TA indicator(s).

  • ONCY’s TA Score: 4 bullish, 5 bearish.
  • UBX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, UBX is a better buy in the short-term than ONCY.

Price Growth

ONCY (@Biotechnology) experienced а +25.81% price change this week, while UBX (@Biotechnology) price change was -1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

ONCY is expected to report earnings on Mar 06, 2025.

UBX is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONCY($75.6M) has a higher market cap than UBX($16.9M). ONCY YTD gains are higher at: -32.904 vs. UBX (-48.202). UBX has higher annual earnings (EBITDA): -20.99M vs. ONCY (-34.96M). UBX has more cash in the bank: 29M vs. ONCY (19.6M). ONCY has less debt than UBX: ONCY (1.06M) vs UBX (20.7M). ONCY (0) and UBX (0) have equivalent revenues.
ONCYUBXONCY / UBX
Capitalization75.6M16.9M447%
EBITDA-34.96M-20.99M167%
Gain YTD-32.904-48.20268%
P/E RatioN/AN/A-
Revenue00-
Total Cash19.6M29M68%
Total Debt1.06M20.7M5%
FUNDAMENTALS RATINGS
ONCY vs UBX: Fundamental Ratings
ONCY
UBX
OUTLOOK RATING
1..100
5755
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
8389
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UBX's Valuation (47) in the Biotechnology industry is in the same range as ONCY (69). This means that UBX’s stock grew similarly to ONCY’s over the last 12 months.

UBX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ONCY (100). This means that UBX’s stock grew similarly to ONCY’s over the last 12 months.

UBX's SMR Rating (98) in the Biotechnology industry is in the same range as ONCY (99). This means that UBX’s stock grew similarly to ONCY’s over the last 12 months.

ONCY's Price Growth Rating (83) in the Biotechnology industry is in the same range as UBX (89). This means that ONCY’s stock grew similarly to UBX’s over the last 12 months.

ONCY's P/E Growth Rating (100) in the Biotechnology industry is in the same range as UBX (100). This means that ONCY’s stock grew similarly to UBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ONCYUBX
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 29 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRSX1.710.46
+36.80%
Foresight Autonomous Holdings Ltd
RF23.840.07
+0.29%
Regions Financial Corp
PDM8.770.01
+0.11%
Piedmont Office Realty Trust
WD97.38-0.37
-0.38%
Walker & Dunlop
ACRV6.36-0.35
-5.22%
Acrivon Therapeutics